Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions News feed Embed this list Save this search Mark all Export Your filters: cql: author="LEBLOND, V" or (type exact bookEditor and editor="LEBLOND, V") Mark journalArticle A1 Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study A Chanan-Khan, P Cramer, F Demirkan, G Fraser, RS Silva, S Grosicki, A Pristupa, A Janssens, J Mayer, NL Bartlett, et al. (2016) LANCET ONCOLOGY. 17(2). p.200-211 Mark journalArticle A1 Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study S CHOQUET, V LEBLOND, R HERBRECHT, G SOCIE, AM STOPPA, P VANDENBERGHE, A FISCHER, F MORSCHHAUSER, G SALLES, W FEREMANS, et al. (2006) BLOOD. 107(8). p.3053-3057 Mark conference C3 Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL) S CHOQUET, R HERBRECHT, G SOCIE, AM STOPPA, P VANDENBERGHE, W FEREMENS, A FISCHER, F MORSCHAUSER, G SALLES, E VILMER, et al. (2002) BLOOD. 100(11).